Hannover Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2024

  1. Circulating long noncoding RNA PDE4DIPP6: A novel biomarker for improving the clinical management of non-ST-segment elevation myocardial infarction

    Clinica Chimica Acta, Vol. 561

  2. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

2023

  1. Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  2. Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach

    Journal of Translational Medicine, Vol. 21, Núm. 1

2022

  1. Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department

    Clinical Biochemistry, Vol. 99, pp. 9-16

2021

  1. Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

  2. Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 6, pp. 653-660

  3. Going the Long Noncoding RNA Way Toward Cardiac Regeneration: Mapping Candidate Long Noncoding RNA Controllers of Regeneration

    Canadian Journal of Cardiology

2020

  1. Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

    Theranostics, Vol. 10, Núm. 19, pp. 8665-8676

  2. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker

    FASEB Journal, Vol. 34, Núm. 3, pp. 4403-4414

2019

  1. Circulating miRNAs as mediators in cell-to-cell communication

    Epigenomics

  2. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: A novel tool for personalized medicine?

    European Heart Journal, Vol. 40, Núm. 20, pp. 1643-1650

  3. Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study

    Scientific Reports, Vol. 8, Núm. 1

  2. Circulating non-coding RNAs as biomarkers to predict and monitor the response to exercise: Chances and hurdles

    European Heart Journal

  3. Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. microRNA-206 correlates with left ventricular function after transcatheter aortic valve implantation

    American journal of physiology. Heart and circulatory physiology, Vol. 313, Núm. 6, pp. H1261-H1266

2016

  1. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes

    Scientific Reports, Vol. 6